Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Plunkett Matthew. Officer active across 1 company, notably CTI Biopharma CORP. In total, 16 filings have been published. Split: 0 buy · 16 sells. Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
400 sharesCommon StockSEC:0000891293-16-000094:0
5,000 sharesCommon StockSEC:0000891293-16-000094:1
3,000 sharesCommon StockSEC:0000891293-16-000094:2
600 sharesCommon StockSEC:0000891293-16-000094:3
700 sharesCommon StockSEC:0000891293-16-000094:4
300 sharesCommon StockSEC:0000891293-16-000094:5
1,600 sharesCommon StockSEC:0000891293-16-000079:0
1,898 sharesCommon StockSEC:0000891293-16-000079:1
800 sharesCommon StockSEC:0000891293-16-000079:2
1,900 sharesCommon StockSEC:0000891293-16-000079:3
1,700 sharesCommon StockSEC:0000891293-16-000079:4
800 sharesCommon StockSEC:0000891293-16-000079:5
300 sharesCommon StockSEC:0000891293-16-000079:6
202 sharesCommon StockSEC:0000891293-16-000079:7
600 sharesCommon StockSEC:0000891293-16-000079:8
200 sharesCommon StockSEC:0000891293-16-000079:9